Cargando…
Transcriptome Profiling of Cardiac Glycoside Treatment Reveals EGR1 and Downstream Proteins of MAPK/ERK Signaling Pathway in Human Breast Cancer Cells
Cardiac glycosides (CGs) constitute a group of steroid-like compounds renowned for their effectiveness in treating cardiovascular ailments. In recent times, there has been growing recognition of their potential use as drug leads in cancer treatment. In our prior research, we identified three highly...
Autores principales: | Pavithran, Honey, Kumavath, Ranjith, Ghosh, Preetam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647710/ https://www.ncbi.nlm.nih.gov/pubmed/37958905 http://dx.doi.org/10.3390/ijms242115922 |
Ejemplares similares
-
Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics
por: Kumavath, Ranjith, et al.
Publicado: (2021) -
Anticancer and Antiviral Properties of Cardiac Glycosides: A Review to Explore the Mechanism of Actions
por: Reddy, Dhanasekhar, et al.
Publicado: (2020) -
Emerging role of pioneer transcription factors in targeted ERα positive breast cancer
por: Pavithran, Honey, et al.
Publicado: (2021) -
Strophanthidin Attenuates MAPK, PI3K/AKT/mTOR, and Wnt/β-Catenin Signaling Pathways in Human Cancers
por: Reddy, Dhanasekhar, et al.
Publicado: (2020) -
Lanatoside C Induces G2/M Cell Cycle Arrest and Suppresses Cancer Cell Growth by Attenuating MAPK, Wnt, JAK-STAT, and PI3K/AKT/mTOR Signaling Pathways
por: Reddy, Dhanasekhar, et al.
Publicado: (2019)